Other conditions Board decisions

The Veteran's claim for service connection for a spinal condition (claimed as arthritis pain in the back) is being remanded due to the need for additional development, including a VA examination.

The Veteran's appeals for earlier effective dates for service connection and special monthly compensation based on loss of use of both upper extremities have been dismissed due to her death.

The Board has remanded the case for further development due to the Veteran's failure to appear at a scheduled Travel Board hearing. The claims file should be returned to the Board after the hearing.

The Board has determined that the Veteran's cause of death, primary central nervous system non-Hodgkin's lymphoma, is due to exposure to ionizing radiation during his military service and thus warrants service connection.

The Veteran's effective date for a 30 percent rating for MVP is set at June 11, 1986, with the Board finding that prior to this date his symptoms were analogous to severe, frequent attacks of paroxysmal tachycardia.

The Board denied the appellant's claim for an effective date prior to March 31, 2008 for the grant of VA death pension benefits with aid and attendance due to lack of evidence showing entitlement before that date.

The Board has determined that the Veteran's acquired psychiatric disorder, including schizoaffective disorder, was not incurred in service and is not related to his military service.

The Board has determined that the Veteran's right inguinal hernia is as likely as not related to his in-service injury, and thus service connection for this condition is granted.

The Board has granted service connection for arthritic degeneration of the right elbow, finding that new evidence supports reopening the claim.

The Board denied the Veteran's claim to reopen his service connection for recurrent perirectal and perianal abscesses, diabetes mellitus type II (diabetes), and an acquired psychiatric disorder. The evidence submitted since October 1990 did not provide new and material evidence.

The Board has determined that the Veteran does not have a chronic ear disability (other than hearing loss) that is related to service, and therefore denied his claim for service connection.

The Board denied the Veteran's claim for service connection for an ulcer disorder, finding that there was no evidence of a chronic condition during service and insufficient medical opinion to support a nexus between current ulcer disorder and service-connected residuals of heat stroke.

The Board found no evidence to support a relationship between the Veteran's service-connected PTSD and his claimed Restless Leg Syndrome or Periodic Limb Movement Disorder, thus denying secondary service connection.

The Board denied the appellant's request to extend his delimiting date for DEA benefits, finding that the request was untimely and not supported by evidence of conditions beyond his control.

The Board denied the Veteran's claims for service connection for defective visual acuity in the right eye and a heart murmur, finding that these conditions preexisted service and were not aggravated by military service.

The Veteran's service-connected PTSD caused his terminal esophageal cancer, which led to his death. The Board granted service connection for the cause of the Veteran's death.

The Veteran's claim for service connection for a left hip disorder was denied. The Board found that there is no medical evidence of record to support the Veteran's claim.

The Board has determined that the Veteran's claims for service connection are not ready for decision due to incomplete evidence and requires further development, including VA examinations.

The Veteran's bilateral foot disabilities, including hallux valgus and pes cavus, are claimed to have been aggravated by his military service. The Board has determined that further development is needed due to the need for a medical opinion regarding the pre-existence of these conditions and their aggravation during service.

Your service-connected residuals of transurethral resection of submucosal bladder tumor with benign prostatic hypertrophy have been rated at 60 percent since September 18, 2009. This rating is based on the requirement for you to use an appliance or absorbent materials that must be changed more than four times a day.